D.B. Root & Company, LLC Eli Lilly & CO Transaction History
D.B. Root & Company, LLC
- $298 Million
- Q1 2025
A detailed history of D.B. Root & Company, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, D.B. Root & Company, LLC holds 394 shares of LLY stock, worth $300,515. This represents 0.11% of its overall portfolio holdings.
Number of Shares
394
Previous 331
19.03%
Holding current value
$300,515
Previous $255,000
27.45%
% of portfolio
0.11%
Previous 0.08%
Shares
4 transactions
Others Institutions Holding LLY
# of Institutions
4,394Shares Held
821MCall Options Held
10MPut Options Held
10.8M-
Pnc Financial Services Group, Inc. Pittsburgh, PA101MShares$77.3 Billion44.13% of portfolio
-
Lilly Endowment Inc Indianapolis, IN96MShares$73.2 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA79.2MShares$60.4 Billion1.22% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$50.2 Billion1.37% of portfolio
-
State Street Corp Boston, MA34.4MShares$26.3 Billion1.2% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $725B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...